InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Indivior Pharmaceuticals, Inc.

INDV Clue Score71
United States Fiscal year ends December CIK 0001625297
$35.83 +1.07% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $35.83 +1,102.35% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue791.0Operating income213.0Net income205.0Fiscal year 2022Revenue901.0 +13.9%Operating income−81.0Net income−44.0 −121.5%EPS, diluted−0.32Fiscal year 2023Revenue1,093.0 +21.3%Operating income−152.0Net income−126.0EPS, diluted−0.92Fiscal year 2024Revenue1,188.0 +8.7%Operating income38.0Net income7.0EPS, diluted0.05Fiscal year 2025Revenue1,239.0 +4.3%Operating income262.0Net income210.0 +2,900.0%EPS, diluted1.64 +3,180.0%
FY2021FY2022FY2023FY2024FY2025
Revenue 791.0 901.0 1,093.0 1,188.0 1,239.0
Growth +13.9% +21.3% +8.7% +4.3%
Operating income 213.0 −81.0 −152.0 38.0 262.0
Net income 205.0 −44.0 −126.0 7.0 210.0
Growth −121.5% +2,900.0%
EPS, diluted n/a −0.32 −0.92 0.05 1.64
Growth +3,180.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Gross margin83.9%Operating margin26.9%Net margin25.9%Free cash flow margin44.1%Fiscal year 2022Gross margin82.4%Operating margin−9.0%Net margin−4.9%Free cash flow margin−1.0%Fiscal year 2023Gross margin83.0%Operating margin−13.9%Net margin−11.5%Free cash flow margin−28.2%Fiscal year 2024Operating margin3.2%Net margin0.6%Free cash flow margin0.6%Fiscal year 2025Operating margin21.1%Net margin16.9%Free cash flow margin−7.5%
FY2021FY2022FY2023FY2024FY2025
Gross margin 83.9% 82.4% 83.0% n/a n/a
Operating margin 26.9% −9.0% −13.9% 3.2% 21.1%
Net margin 25.9% −4.9% −11.5% 0.6% 16.9%
Free cash flow margin 44.1% −1.0% −28.2% 0.6% −7.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow353.0Capital expenditure−4.0Free cash flow349.0Buybacks−101.0Fiscal year 2022Operating cash flow−4.0Capital expenditure−5.0Free cash flow−9.0 −102.6%Buybacks−90.0Fiscal year 2023Operating cash flow−300.0Capital expenditure−8.0Free cash flow−308.0Buybacks−33.0Fiscal year 2024Operating cash flow36.0Capital expenditure−29.0Free cash flow7.0Buybacks−173.0Fiscal year 2025Operating cash flow−27.0Capital expenditure−66.0Free cash flow−93.0 −1,428.6%Buybacks−11.0
FY2021FY2022FY2023FY2024FY2025
Operating cash flow 353.0 −4.0 −300.0 36.0 −27.0
Capital expenditure −4.0 −5.0 −8.0 −29.0 −66.0
Free cash flow 349.0 −9.0 −308.0 7.0 −93.0
Growth −102.6% −1,428.6%
Buybacks −101.0 −90.0 −33.0 −173.0 −11.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash1,102.0Total debt239.0Net cash (debt)863.0Shareholders’ equity121.0Debt to equity1.98Fiscal year 2022Cash774.0Total debt237.0Net cash (debt)537.0Shareholders’ equity−15.0Fiscal year 2023Cash316.0Total debt240.0Net cash (debt)76.0Shareholders’ equity−184.0Fiscal year 2024Cash319.0Total debt333.0Net cash (debt)−14.0Shareholders’ equity−337.0Fiscal year 2025Cash195.0Total debt319.0Net cash (debt)−124.0Shareholders’ equity−98.0
FY2021FY2022FY2023FY2024FY2025
Cash 1,102.0 774.0 316.0 319.0 195.0
Total debt 239.0 237.0 240.0 333.0 319.0
Net cash (debt) 863.0 537.0 76.0 −14.0 −124.0
Shareholders’ equity 121.0 −15.0 −184.0 −337.0 −98.0
Debt to equity 1.98 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
353.0 −4.0 −300.0 36.0 −27.0
Growth −101.1% −175.0%
n/a 16.0 15.0 16.0 10.0
Investment
−4.0 −5.0 −8.0 −29.0 −66.0
calc 349.0 −9.0 −308.0 7.0 −93.0
Growth −102.6% −1,428.6%
calc 2.30 −0.06 −2.25 0.05 −0.73
−14.0 −222.0 −95.0 69.0 −66.0
Financing
−94.0 −101.0 −64.0 −102.0 −30.0
−101.0 −90.0 −33.0 −173.0 −11.0

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.